ImmunityBio, Inc.
IBRX
$2.84
$0.176.37%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -63.88% | -43.78% | -31.31% | 374.34% | 86.81% |
| Total Receivables | 716.71% | -16.26% | 110.92% | -37.18% | 45.97% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 20.87% | 19.68% | 50.38% | 60.66% | 51.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -31.87% | -32.03% | -16.63% | -8.44% | 5.82% |
| Total Current Assets | -44.23% | -37.23% | -24.15% | 263.38% | 72.46% |
|
|
|||||
| Total Current Assets | -44.23% | -37.23% | -24.15% | 263.38% | 72.46% |
| Net Property, Plant & Equipment | -6.55% | -6.69% | -7.27% | -9.45% | -9.94% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -12.30% | -12.11% | -15.69% | -15.45% | -15.02% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.37% | 23.26% | 5.35% | -7.54% | -13.38% |
| Total Assets | -24.19% | -24.09% | -15.69% | 52.57% | 16.68% |
|
|
|||||
| Total Accounts Payable | -2.65% | -26.86% | -49.82% | -20.29% | -58.69% |
| Total Accrued Expenses | -16.60% | -4.11% | -32.29% | -43.82% | -41.75% |
| Short-term Debt | -- | -15.39% | -7.49% | -- | -99.87% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.80% | 40.66% | 58.15% | 3.40% | 109.54% |
| Total Finance Division Other Current Liabilities | 6.75% | -42.39% | -58.36% | -47.07% | -36.93% |
| Total Other Current Liabilities | 6.75% | -42.39% | -58.36% | -47.07% | -36.93% |
| Total Current Liabilities | -8.47% | -5.73% | -32.51% | -89.88% | -90.48% |
|
|
|||||
| Total Current Liabilities | -8.47% | -5.73% | -32.51% | -89.88% | -90.48% |
| Long-Term Debt | -8.05% | -10.83% | 44.42% | 282.35% | 246.24% |
| Short-term Debt | -- | -15.39% | -7.49% | -- | -99.87% |
| Capital Leases | -13.36% | -12.82% | -6.49% | -18.29% | -17.55% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -79.94% | -77.44% | -4.02% | 207.63% | 719.84% |
| Total Liabilities | -18.08% | -20.11% | 31.51% | 21.92% | 24.74% |
|
|
|||||
| Common Stock & APIC | 20.37% | 21.49% | 11.01% | 27.19% | 22.28% |
| Retained Earnings | -13.21% | -13.96% | -21.54% | -22.70% | -24.09% |
| Treasury Stock & Other | 285,185.71% | 11,880.00% | -86.99% | 80.00% | 78.79% |
| Total Common Equity | 14.53% | 16.68% | -80.99% | -8.76% | -30.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.53% | 16.68% | -80.99% | -8.76% | -30.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -7.77% | -7.71% | -8.02% | 132.90% | 137.65% |
| Total Equity | 14.54% | 16.69% | -81.22% | -8.09% | -29.95% |
|
|
|||||